Primary surgery provides the most effective
form of treatment for early-stage non small cell lung cancer
(NSCLC). Proponents of wedge and segmental resection have yet
to demonstrate that less extensive surgery provides adequate
disease control, even in early stages of disease. The role of
lymph node sampling versus total lymph node dissection remains
unresolved but is the subject of an ongoing clinical trial.
Limited resection might have a role in the management of small
lung lesions detected by screening and in the management of
bronchoalveolar hyperplasia.
Lobectomy remains the standard of care for patients who
have early-stage lung cancer (stages Ia and Ib). The role
of less extensive surgery has yet to be defined.
Some surgeons have advocated use of wedge resection or segmental
resection for early-stage lung cancer. Less extensive surgery
confers less morbidity and lower mortality risk. With modern
surgical technique, wedge resection would likely result in
operative mortality much less than 1% in selected patients.
Several studies, however, have demonstrated that lobectomy
substantially lowers the risk of local or regional recurrence
compared to less extensive surgery. Long term survival is
also improved. Thus at this time, lobectomy maintains superiority
over wedge or segmental resection even for patients who have
early-stage NSCLC (T1 N0).
Local/Regional Recurrence - T1 N0
Tumors
Tumor
size | Segmentectomy | Lobectomy |
< 2 cm | 9/40
(22.5%) | 1/35
(2.8%) | 2
- 3 cm | 4/15
(26.6%) | 1/10
(10%) | Total | 13/55
(23.6%) | 2/45
(4.4%) |
Adapted from Warren and Faber, 1993
|
Limited resection followed by local radiation therapy represents
a potentially more effective alternative to wedge resection
or segmental resection alone. Several retrospective studies
have suggested that local radiation therapy does reduce the
risk of recurrence after less extensive surgery. The efficacy
of combined treatment has yet to be evaluated in prospective,
controlled clinical trials.
The role of lymph node dissection in early-stage lung cancer
also remains unresolved at this time. Patients who have hilar
nodal disease should undergo total lymph node dissection.
The potential for limited lymph node sampling in the absence
of hilar node metastasis has yet to be determined.
To this end the American College of Surgeons Oncology Group
has initiated a large multicenter clinical trial to address
the role of lymph node sampling at the time of surgery. Patients
who do not have hilar nodal disease are randomized to complete
lymph node dissection or lymph node sampling. The trial should
answer the question of whether lymph node dissection improves
overall survival by elimination of occult metastatic disease.
Lung cancer screening by spiral computed tomography (CT)
has raised the possibility of a role for limited resection.
Some surgeons question the appropriateness of lobectomy for
a lesion of less than 1 cm detected by screening CT. The emergence
of spiral CT in the diagnoses of early stage lung cancer raises
reconsideration of the role of wedge and segmental resection
for patients who have very small early-stage lesions.
A possible role for limited resection also may exist for
treatment of bronchoalveolar hyperplasia. Japanese investigators
have begun several prospective studies to evaluate the role
of wedge resection for confirmed hyperplasia that has no solid
component.
Until data from appropriately controlled clinical trial
dictate otherwise, primary surgery will remain the gold standard
for treatment of early-stage lung cancer. |